NextSeq 2000 Sequencing System
Solicitation number 2023RSS0062
Publication date
Closing date and time 2023/08/17 16:00 EDT
Last amendment date
Description
*ACAN is also posted on MERX.com reference # 0000253994*
The university intends to purchase Illumina Canada’s NextSeq 2000 sequencing system, trading in an existing Illumina NextSeq 500 system. The research lab currently has 3 clinical tests (COVID sequencing for variant, TST 170, and TSO500 for solid tumour sequencing) validated on the NextSeq 550 NGS system additionally are in the process of validating more tests such as clinical exome sequencing. It is critical that the sequencing platform be compatible with the existing assays routinely run in the lab.
Additional details are included in the ACAN document.
Contract duration
The estimated contract period will be 0 month(s), with a proposed start date of 2023/08/17.
Trade agreements
-
Canadian Free Trade Agreement (CFTA)
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
Contact information
Contracting organization
- Organization
-
University of Calgary
- Address
-
2500 University Drive NWCalgary, Alberta, T2N 1N4Canada
- Contracting authority
- Melissa Innes
- Phone
- 403-220-5188
- Email
- mjinnes@ucalgary.ca
- Fax
- 403-220-282-8451
- Address
-
Physical Plant Building, PP65 3838 - 24th Avenue NWCalgary, Alberta, T2N 1N4Canada
Bidding details
Full details for this tender opportunity are available on a third-party site
Click on the button below to be directed to this website. Note that on the third-party site you may need an account to view and/or bid on this tender. Information on any fees or additional costs to access the full details is outlined in the Description tab of this tender opportunity.